Navigation Links
PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
Date:8/6/2008

ngs $31,474 $13,656 $30,463

Long-term debt $38,465 $38,443 $277

Stockholders' equity $428,091 $397,266 $316,616

(a) Fiscal Year 2007 numbers have been adjusted to reflect Fiscal Year

2008 presentation. Certain direct costs have been moved to selling,

general and administrative to ensure consistency among all business

segments.

(b) Represents an $11.1 million reversal of certain U.S. tax valuation

reserves, which were offset by $2.4 million in adjustments to the

Netherlands tax reserves.

PAREXEL International Corporation

Consolidated Condensed Statement of Income

(In thousands, except per share data)

Unaudited

Twelve Months Ended

June 30, 2008 June 30, 2007

As As

Reported Adjustments Adjusted Reported(a)

Service revenue $964,283 $964,283 $741,955

Reimbursement revenue 198,687 198,687 176,149

Total revenue 1,162,970 1,162,970 918,104

Costs and expenses:

Direct costs 629,399 629,399 483,887

Reimbursable out-of-

pocket expenses 198,687 198,687 176,149

Selling, general and

administrative 211,392 211,392 169,681

Depreciation 33,005 33,005 26,546

Amortization 4,681 4,681 4,309

Restructuring benefit (860) 860 (b) -
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
2. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call
3. PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
4. PAREXEL Expands Global Clinical Logistics Capabilities
5. Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
6. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
7. PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting
8. PAREXEL Reaches Agreement To Acquire ClinPhone
9. PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference
10. PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
11. PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... , , , , Multiporator / Electroporator 2510 , , , ... Transformation Protocol , Protocol No. 4308 915.524 03/2002 , ... , , , , ... , Cell type , Bacteria, ...
... , , , Multiporator / Electroporator 2510 , , , , ... Transformation Protocol , Protocol No. 4308 915.519 12/2001 , ... , , , ... , Cell type , Bacteria, gram positive, ...
... , , , Multiporator / Electroporator 2510 , , , , , ... Transformation Protocol , Protocol No. 4308 915.520 12/2001 , ... , , , Microorganism , ... Cell type , Bacteria, gram positive, ...
Cached Biology Technology:Mycobacterium tuberculosis 2Lactococcus lactis 2Listeria monocytogenes 2
(Date:12/22/2014)... 2014 Research and Markets ... of the "The Global Watermarking and ... http://photos.prnewswire.com/prnh/20130307/600769 ... of the global digital media watermarking and ... monitor piracy by securely and invisibly embedding ...
(Date:12/19/2014)... 2014  23andMe, Inc., the leading personal genetics company, ... fine-scale differences in genetic ancestry of individuals from across ... Since immigrants first arrived more than four hundred years ... served as a meeting place for peoples from different ... ongoing mixing of peoples with African, European, and American ...
(Date:12/17/2014)... 15, 2014  HITLAB SM announced today ... audit to confirm its adherence to current U.S. ... enables HITLAB to conduct regulated smart device and ... for patient safety and research quality. ... quality, and delivery with innovative technology," said ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... called microRNAs, control protein production primarily by causing the ... to be disabled by the cell, according to Whitehead ... microRNAs control protein production by causing the mRNAs to ... microRNAs impart by jamming the process that translates mRNAs ...
... Aug. 16, 2010 A very aggressive disease with ... higher exposure to estrogens, according to a group of ... Dr. Jan-ke Gustafsson, Robert A. Welch Professor in UH,s ... a paper titled "Estrogen-dependent gallbladder carcinogenesis in LXRβ-/- female ...
... WI, August 16th, 2010 - Fields amended with ... according to studies by USDA-Agricultural Research Service (ARS) ... about the agricultural pollutants that can build up ... nearby streams and rivers. Poultry producers ...
Cached Biology News:RNA snippets control protein production by disabling mRNAs 2RNA snippets control protein production by disabling mRNAs 3Gallbladder cancer may be linked to estrogens, says UH team 2Arsenic in field runoff linked to poultry litter 2
Request Info...
...
... potent inhibition of RNase A-type ribonucleases Product ... of nonhuman origin that binds noncovalently and ... A, B, and C). It does not ... U2, or CL3. QIAGEN RNase Inhibitor inhibits ...
Request Info...
Biology Products: